Moonshot AI Faces Equity Dispute Before Hong Kong IPO, Claims May Exceed $700 Million
nashnova research
Moonshot AI plans to list in Hong Kong in early 2027, targeting roughly $5 billion in proceeds, but investors in predecessor company Recurrent.ai allege the founders diverted resources — with claims potentially exceeding $700 million at the latest $50 billion valuation. Whether the dispute settles before listing will directly shape the final pricing.
What is this equity dispute actually about?
Some Recurrent.ai investors allege that Moonshot AI founder and CEO Yang Zhilin and CTO Zhang Yutao launched the new company without board approval and transferred technology and business resources from Recurrent.ai.
A legal letter dated March 11 claims servers holding large-language-model data were moved without authorization to a Moonshot AI subsidiary in April 2023, and key records were deleted in September 2024.
Yang's legal representatives responded that Recurrent.ai board members had previously agreed to Moonshot AI's formation, denying any improper personal gain. This means → the two sides flatly contradict each other, and the core facts remain independently unverified.
How does the claim reach $700 million?
Recurrent.ai already received 9.5% founding equity in Moonshot AI at inception; the claimants now seek an additional 10.5% of the original share capital.
In plain terms = the claimants believe they were owed far more than that initial 9.5% — the gap, priced at the latest valuation, is real money.
At Moonshot AI's June 2026 valuation of roughly $30 billion, 10.5% translates to over $700 million; at the latest $50 billion valuation, the figure would be higher still.
Separately, investors are considering a lawsuit in the Cayman Islands over President Zhang Yutong's receipt of a large equity stake, with the dispute centering on whether disclosure was adequate.
How far along is the IPO?
Moonshot AI confidentially filed its IPO application with the Hong Kong Stock Exchange in September 2026, targeting a first-quarter 2027 listing and aiming to raise roughly $5 billion.
Bank of America is the overall coordinator; CICC, Deutsche Bank, and Goldman Sachs are sponsors. Preliminary investor outreach may begin in October 2026.
The latest private funding round lifted the valuation to $50 billion, a sharp jump from roughly $31.5 billion in the summer 2026 round. This reflects strong market expectations for Moonshot AI's commercialization trajectory.
What do the business fundamentals look like?
Hong Kong Economic Times reports annual recurring revenue (ARR — the revenue the company can predictably count on each year) of roughly $1 billion, expected to reach $2 billion by December 2026.
The Kimi model family continues to expand. Kimi K3, launched in July 2026 with 2.8 trillion parameters, is positioned as the world's largest open-weight AI model.
Backers include Alibaba, Tencent, Meituan, and China Mobile. This means → capital and resources are not the bottleneck, but a high valuation also means investors have less tolerance for any growth shortfall.
Beyond the equity dispute, what other risks loom?
Moonshot AI and DeepSeek are both involved in a Chinese data-security investigation, which could affect valuations and listing timelines.
In plain terms = regulatory scrutiny and the legal dispute are two blades hanging overhead — either one falling could delay or re-price the IPO.
Analysts believe the equity dispute alone is unlikely to block the listing outright, but it will force investors to re-examine IP ownership, shareholder rights, and disclosure practices — factors that feed directly into the final pricing.
市场有风险，内容仅供研究参考，不构成投资建议。